Vipul Desai, MD
Infectious Disease · The Woodlands, TXNPI 1891960969
Payments from drug & device makers
Across 1,369 payments — averaging $73.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Melinta Therapeutics, LLC$33K
- Cumberland Pharmaceuticals, Inc.$18K
- Paratek Pharmaceuticals, Inc.$13K
- Ferring Pharmaceuticals Inc.$5K
- AbbVie$5K
- Gilead$5K
- plus $21K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Melinta Therapeutics, LLC | 107 | $33,117 |
| Cumberland Pharmaceuticals, Inc. | 71 | $18,135 |
| Paratek Pharmaceuticals, Inc. | 95 | $13,278 |
| Ferring Pharmaceuticals Inc. | 16 | $5,403 |
| AbbVie(2 entities) | 138 | $5,340 |
| Gilead | 239 | $4,563 |
| Cipla USA Inc. | 10 | $4,541 |
| Tetraphase Pharmaceuticals, Inc. | 21 | $4,396 |
| Viiv Healthcare Company | 185 | $2,931 |
| Insmed, Inc. | 79 | $1,719 |
| Smith+Nephew | 109 | $1,500 |
| Merck | 112 | $1,489 |
| Astellas Pharma US Inc | 43 | $1,433 |
| Shionogi Inc | 40 | $746 |
| La Jolla Pharmaceutical Company | 17 | $547 |
| GRT US Holding, Inc. | 11 | $416 |
| EMD Serono, Inc. | 11 | $234 |
| Aimmune Therapeutics, Inc. | 6 | $170 |
| Pfizer | 7 | $161 |
| Johnson & Johnson | 8 | $139 |
| Mayne Pharma Commercial LLC | 8 | $132 |
| Theratechnologies Inc. | 4 | $108 |
| Osiris Therapeutics Inc. | 5 | $86 |
| Organogenesis Inc. | 5 | $84 |
| Abbott | 1 | $67 |
| Endo Pharmaceuticals Inc. | 4 | $58 |
| Tersera Therapeutics LLC | 2 | $54 |
| Dynavax Technologies Corporation | 3 | $49 |
| Octapharma USA, Inc. | 1 | $41 |
| Napo Pharmaceuticals Inc | 2 | $41 |
| Imbed Biosciences Inc. | 1 | $36 |
| KCI USA, Inc. | 2 | $31 |
| Seqirus USA Inc | 2 | $25 |
| Tactile Systems Technology Inc | 1 | $19 |
| Convatec Inc. | 1 | $17 |
| ETS Wound Care LLC | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $14 |
How this compares
$101,136 in reported general payments places this provider in the 90th percentile of 576 infectious disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in The Woodlands
- Gene VoskuhlSherman$69.5M
- Mezgebe BerheDallas$11M
- Eleftherios MylonakisHouston$6.4M
- Mamta JainDallas$3.7M
- Cheryl McDonaldFort Worth$3.1M
- Ogechika AlozieEl Paso$2.5M
- Roberto ArduinoHouston$2.1M
- Issam RaadHouston$2M
- Joseph GatheHouston$1.9M
- Kevin GrimesHouston$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.